Latest News

Celerion Named Best Translational Clinical Pharmacology Comp...

Celerion Named Best Translational Clinical Pharmacology Company 2016 Lincoln, NE (October 5, 2016) —...

Newsletter: Q4 2016

Celerion Recognized by Biopharmaceutical Clients as a Leader...

Celerion Recognized by Biopharmaceutical Clients as a Leader in Contract Research Quality Benchmarki...

Assign Clinical Research Joins Celerion

Assign Clinical Research Joins Celerion (Lincoln, NE Jan 11, 2016) – Celerion is pleased to announce...

Celerion Expands its Cell-Based Assays Capabilities in Globa...

Celerion Expands its Cell-Based Assays Capabilities in Global Bioanalytical Services (Lincoln, NE; N...

Celerion Completes Recapitalization Through Investment by MT...

Celerion Completes Recapitalization Through Investment by MTS Capital Health Partners (Lincoln, NE;...

Celerion Announces Membership into the Cardiac Safety Resear...

Celerion Announces Membership into the Cardiac Safety Research Consortium (CSRC) (Lincoln, NE; Oct 1...

Celerion Expands Ophthalmological Capabilities to Patient Po...

(Lincoln, NE; Sep 30, 2014) – Celerion announces the expansion of ophthalmological services in our B...

Celerion Appoints Dr. Robert Lester as Chief Cardiologist, G...

Celerion Appoints Dr. Robert Lester as Chief Cardiologist, Global Medical Director of Cardiac Safety...